These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16827639)

  • 1. Effects of intraoperative versus postoperative administration of rabbit antithymocyte antibodies on 1-year renal function in renal transplant patients.
    Kamar N; Esposito L; Ribes D; Tkaczuk J; Cointault O; Lavayssiere L; Abbal M; Durand D; Rostaing L
    Exp Clin Transplant; 2006 Jun; 4(1):429-38. PubMed ID: 16827639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients.
    Esposito L; Kamar N; Tkaczuk J; Abbal M; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):785-7. PubMed ID: 15848531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety.
    Esposito L; Kamar N; Durand D; Rostaing L
    Transplant Proc; 2005 Mar; 37(2):892-4. PubMed ID: 15848567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
    Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
    Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
    Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J; Reese PP; Patel HJ; Jakobowski D; Goral S; Doll SL; Abt PL; Bloom RD
    Transplantation; 2012 Sep; 94(5):506-12. PubMed ID: 22895613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
    Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression.
    Pankewycz O; Leca N; Kohli R; Wallace PK; Said M; Feng L; Alnimri M; Patel S; Laftavi MR
    Transplant Proc; 2011 Mar; 43(2):462-5. PubMed ID: 21440734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis.
    Kamel MH; Mohan P; Conlon PJ; Little DM; O'Kelly P; Hickey DP
    Pediatr Transplant; 2006 Nov; 10(7):816-21. PubMed ID: 17032428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
    Kawaguchi A; Szentpetery S; Mohanakumar T; Barnhart GR; Lower RR
    J Heart Transplant; 1987; 6(4):214-7. PubMed ID: 3312532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
    Tsapepas DS; Mohan S; Tanriover B; Dube G; Crew RJ; Cohen DJ; Hardy MA; Sandoval PR; Ratner LE
    Transplantation; 2012 Aug; 94(4):325-30. PubMed ID: 22814328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial.
    Büchler M; Longuet H; Lemoine R; Herr F; Gatault P; Thibault G; Ternant D; Foulon C; Pilorge B; Lemay D; Sung C; Halimi JM; Baron C; Lebranchu Y
    Transpl Immunol; 2013 Mar; 28(2-3):120-6. PubMed ID: 23507258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
    Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
    Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients.
    Marvin MR; Droogan C; Sawinski D; Cohen DJ; Hardy MA
    Transplantation; 2003 Feb; 75(4):488-9. PubMed ID: 12605115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH; Mohan P; Little DM; Awan A; Hickey DP
    J Urol; 2005 Aug; 174(2):703-7. PubMed ID: 16006954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep vein thrombosis during rabbit antithymocyte globulin administration.
    Mathis AS; Rao V
    Transplant Proc; 2004 Dec; 36(10):3250-1. PubMed ID: 15686740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.
    Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM
    Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation.
    Carrier M; Pelletier GB; Cartier R; Leclerc Y; Robitaille D; Pelletier LC
    Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.